GetTopicDetailResponse(id=ac671141e83d, topicName=新輔助免疫, introduction=, content=化療 肺癌 新輔助免疫, image=null, comments=0, allHits=931, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon May 06 22:41:04 CST 2024, time=2024-05-06, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=490319, tagList=[TagDto(tagId=490319, tagName=新輔助免疫)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2236019, encodeId=5e6d2236019b8, content=<a href='/topic/show?id=84b812111520' target=_blank style='color:#2F92EE;'>#肺上溝瘤#</a> <a href='/topic/show?id=ac671141e83d' target=_blank style='color:#2F92EE;'>#新輔助免疫#</a>, objectTitle=張真發(fā)教授組稿｜李躍：新輔助免疫聯(lián)合化療治療肺上溝瘤的手術(shù)經(jīng)驗(yàn)分享, objectType=article, longId=850517, objectId=d28585051e92, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719546536055_92910.png, objectUrl=/article/show_article.do?id=d28585051e92, replyNumber=0, likeNumber=68, createdTime=2024-11-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d28585051e92, moduleTitle=張真發(fā)教授組稿｜李躍：新輔助免疫聯(lián)合化療治療肺上溝瘤的手術(shù)經(jīng)驗(yàn)分享, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d28585051e92)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2202088, encodeId=44ee2202088d9, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化療#</a> <a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=ac671141e83d' target=_blank style='color:#2F92EE;'>#新輔助免疫#</a>, objectTitle=2024 AATS｜廣東省人民醫(yī)院（口頭匯報(bào)）：EGFR突變肺癌接受新輔助免疫聯(lián)合化療, objectType=article, longId=824566, objectId=d96882456634, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016274166_4754896.png, objectUrl=/article/show_article.do?id=d96882456634, replyNumber=0, likeNumber=119, createdTime=2024-05-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d96882456634, moduleTitle=2024 AATS｜廣東省人民醫(yī)院（口頭匯報(bào)）：EGFR突變肺癌接受新輔助免疫聯(lián)合化療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d96882456634)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-05-06發(fā)表于上海
